Atropine Sulfate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Dec 20, 2023.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6251-10
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)
Initial Posting
Dec 20, 2023

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.